EOFlow v Insulet (CoA, 4 February 2026)
| Date | 4 February 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.2 |
| Case number(s) | UPC_CoA_930/2025 |
| Registry reference | UPC_CoA_930/2025 |
| Parties | EOFlow Co., Ltd. v. Insulet Corporation |
Official decision (PDF) · UPC registry entry
Case timeline
- 29 January 2026 : EOFlow v Insulet (CoA, 29 January 2026) UPC-COA-0000930/2025
- 18 March 2026 : EOFLOW v Insulet (CoA, 18 March 2026) UPC-COA-0000930/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
The Court of Appeal holds inadmissible the appeal by EOFlow Co., Ltd. against the order of the Milan Central Division of 4 December 2025 (UPC_CFI_1167/2025), which, at the request of Insulet Corporation, had imposed penalty payments of EUR 150,000 for non-compliance with the provisional measures ordered by the Court of Appeal on 30 April 2025 on EP 4 201 327, together with EUR 10,000 in costs. The order confirms that an order imposing penalty payments may be appealed only with leave, and that leave must be granted expressly.
Question
May a first instance order imposing penalty payments, and deciding on the costs of those proceedings, be appealed without leave?
Decision
An order imposing penalty payments falls neither under Art. 73(2)(a) UPCA nor under Rule 220.1(c) RoP, Rule 354.4 RoP merely clarifies this, and an appeal requires leave (paragraphs 16 to 19). The Milan Central Division had expressly granted leave on the confidentiality issue but only noted that the penalty was subject to appeal. Leave cannot be presumed (paragraphs 20 to 22). Since no leave was sought, discretionary review under Rule 220.3 RoP is not available (paragraphs 23 and 24). A cost order deciding both who bears the costs and their amount follows the remedy against the main decision, Rule 221 RoP covering only disputes on the amount (paragraph 29). The appeal is dismissed as inadmissible, and the application for suspensive effect fails with it (paragraphs 31 to 33). EOFlow may, within 14 days, cure its appeal on the dismissal of its confidentiality requests, which did not state the order sought (paragraph 34).
Key points for practice
- An appeal against penalty payments imposed at first instance requires express leave, given in the order itself or in a separate order issued within 15 days. A statement that an appeal is possible is not leave (paragraphs 21 and 22).
- Costs fixed in the same order share the fate of the main appeal (paragraphs 29 and 30).
Provisions applied
- Agreement on a Unified Patent Court
- Arts 73(2)(a) and (b) and 82(4)
- Rules of Procedure
- Rules 157, 220, 221, 223, 229.1 and 354.4
- Case law cited
- Insulet v EOFlow, Court of Appeal, 30 April 2025 (UPC_CoA_768/2024), Suinno v Microsoft, Court of Appeal, 9 October 2024, UPC_CoA_586/2024, Photon Wave v Seoul Viosys, Court of Appeal, 15 October 2024, PC 01/2024, Ballinno v Kinexon, Court of Appeal, 12 May 2025, UPC_CoA_328/2024, Total v Texas Instruments, Court of Appeal, 14 January 2025, UPC_CoA_651/2024, Amazon v InterDigital, Court of Appeal, 29 December 2025 (UPC_CoA_936/2025).
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
UPC_CoA_930/2025official number
UPC_CFI_1167/2025Parties
- defendantInsulet Corporation26 decisions in the corpusFollow this party
- claimantEOFlow Co., Ltd.22 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 4 December 2025 Insulet v EOFLOW (CFI, 4 December 2025) Application RoP262A · UPC_CFI_1167/2025
The Milan Central Division ordered EOFLOW to pay a penalty of EUR 150,000 for violating the preliminary injunction granted by the Court of Appeal on 30 April 2025, on the basis of evidence that EOFLOW had exported 11,520 insulin pump devices to Italy and Sweden between May and July 2025 in breach of that injunction, an…
- 29 January 2026 EOFlow v Insulet (CoA, 29 January 2026) Application RoP262.2 · UPC_CoA_930/2025
Les pièces déposées comme confidentielles sont rendues accessibles à l’autre partie et la demande de restriction d’usage est rejetée : les informations communiquées en exécution d’une injonction ne sont protégées que par une demande au titre de la règle 262A.
- 4 February 2026 EOFlow v Insulet (CoA, 4 February 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
- 18 March 2026 EOFLOW v Insulet (CoA, 18 March 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
La cour d'appel rejette l'appel d'EOFlow : les informations communiquées à Insulet sans ordonnance au titre de la règle 262A ne sont plus des secrets d'affaires ni des informations confidentielles, aucune limitation implicite d'usage n'existant.
What the record states
- Nature of the act
- Appeal RoP220.2
- Outcome (Dhenne Avocats summary)
- L’appel contre l’ordonnance prononçant une astreinte et fixant les frais est irrecevable faute d’autorisation expresse de la division de première instance. La demande d’effet suspensif est rejetée.
- Appeal
- Decision of the Court of Appeal (first instance cited: UPC_CFI_1167/2025).
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 201 327mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- EOFLOW v Insulet (CoA, 18 March 2026) cited in this record
- EOFlow v Insulet (CoA, 29 January 2026) cited in this record
- Amazon.com v InterDigital VC Holdings (CoA, 29 December 2025) cited in this record
- Insulet v EOFLOW (CFI, 4 December 2025) cited in this record
- Insulet v EOFLOW (CoA, UPC_CoA_768/2024, 1 May 2025) cited in this record
- Align Technology v Angelalign Technology (CFI, 3 July 2026) cites this decision
- Huawei Technologies v Quinn Emanuel Urquhart & Sullivan (CoA, 29 June 2026) cites this decision
- Speed Care Mineral v Teleflex Life Sciences II (CoA, 10 June 2026) cites this decision
- ADOBE v KEEEX (CoA, 8 May 2026) cites this decision
- Adobe v KEEEX (CoA, 30 April 2026) cites this decision
- EOFlow v Insulet (CoA, 26 February 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 201 327Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith recorded proprietor: Insulet Corp | Mentioned in the analysis (role not qualified) Also mentioned in 25 other decision(s): EOFLOW v Insulet (CFI, 22 July 2025) · EOFLOW v Insulet (CoA, 18 March 2026) · EOFlow v Insulet (CoA, 26 February 2026) · EOFlow v Insulet (CoA, 29 January 2026) · Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 2 · Insulet v EOFLOW (CFI, 15 October 2025) · EOFLOW v Insulet (CFI, ORD_26828/2025, 5 June 2025) · EOFLOW v Insulet (CFI, 28 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.